Home > Insider Trading > Filing (0001209191-11-058045)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1459450	Myrexis Inc.	MYRX	Pharmaceutical Preparations (2834)	263996918

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1416041	P. Gerald Belle	C/O Myrexis, Inc. 305 Chipeta Way Salt Lake City UT 84108		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-11-22	34,200	$2.48	34,500	No	4	P	Direct
Common Stock	Acquisiton	2011-11-23	6,100	$2.48	40,600	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The shares were purchased in multiple transactions at prices ranging from $2.46 to $2.48 per share. The price reported above is the weighted average purchase price. See footnote (4)
Includes 300 shares acquired on June 30, 2009 in a pro rata distribution by Myriad Genetics, Inc. ("Myriad Genetics") of all of its shares of the Issuer's common stock in connection with the spin-off of the Issuer by Myriad Genetics.
The shares were purchased in multiple transactions at prices ranging from $2.46 to $2.48 per share. The price reported above is the weighted average purchase price. See footnote (4)
The Reporting Person hereby undertakes to provide upon request to the staff of the SEC, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth above.